Janus Henderson Group’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.7M | Buy |
446,828
+425,374
| +1,983% | +$23.5M | 0.01% | 529 |
|
|
2025
Q1 | $1.05M | Hold |
21,454
| – | – | ﹤0.01% | 1595 |
|
|
2024
Q4 | $828K | Hold |
21,454
| – | – | ﹤0.01% | 1783 |
|
|
2024
Q3 | $965K | Hold |
21,454
| – | – | ﹤0.01% | 1685 |
|
|
2024
Q2 | $743K | Sell |
21,454
-281
| -1% | -$9.73K | ﹤0.01% | 1783 |
|
|
2024
Q1 | $628K | Buy |
21,735
+1
| +0% | +$29 | ﹤0.01% | 1897 |
|
|
2023
Q4 | $499K | Sell |
21,734
-41
| -0.2% | -$941 | ﹤0.01% | 1986 |
|
|
2023
Q3 | $364K | Buy |
21,775
+20
| +0.1% | +$334 | ﹤0.01% | 2095 |
|
|
2023
Q2 | $601K | Buy |
21,755
+4,505
| +26% | +$124K | ﹤0.01% | 1875 |
|
|
2023
Q1 | $397K | Buy |
+17,250
| New | +$397K | ﹤0.01% | 2144 |
|
|
2022
Q1 | – | Sell |
-8,014
| Closed | -$274K | – | 2694 |
|
|
2021
Q4 | $274K | Buy |
+8,014
| New | +$274K | ﹤0.01% | 2240 |
|